Scarica l'app Stockscreener
22.56
1.31%
-0.30
Dopo l'orario di chiusura:
22.60
0.04
+0.18%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BAX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$22.86
Aprire:
$22.73
Volume 24 ore:
5.86M
Relative Volume:
0.84
Capitalizzazione di mercato:
$11.59B
Reddito:
$11.89B
Utile/perdita netta:
$-560.00M
Rapporto P/E:
-20.51
EPS:
-1.1
Flusso di cassa netto:
$191.00M
1 W Prestazione:
-2.76%
1M Prestazione:
-8.07%
6M Prestazione:
-32.86%
1 anno Prestazione:
-42.12%
Intervallo 1D:
$22.52
$22.91
Intervallo di 1 settimana:
$22.52
$23.81
Portata 52W:
$21.33
$39.57
Baxter International Inc Stock (BAX) Company Profile
Nome
Baxter International Inc
Settore
Industria
Telefono
(224) 948-2000
Indirizzo
ONE BAXTER PARKWAY, DEERFIELD, IL
Confronta BAX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
22.56 | 11.74B | 11.89B | -560.00M | 191.00M | -1.10 |
|
ISRG
Intuitive Surgical Inc
|
443.99 | 160.51B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
186.05 | 53.46B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
274.19 | 40.35B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
75.00 | 37.18B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
259.94 | 18.03B | 2.96B | 487.70M | 344.00M | 6.68 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-04 | Downgrade | Stifel | Buy → Hold |
| 2025-08-01 | Downgrade | Goldman | Buy → Neutral |
| 2025-02-26 | Ripresa | Goldman | Buy |
| 2025-02-24 | Aggiornamento | Argus | Hold → Buy |
| 2025-02-20 | Ripresa | Barclays | Overweight |
| 2024-07-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-10 | Downgrade | TD Cowen | Buy → Hold |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-06 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-12-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Downgrade | Citigroup | Buy → Neutral |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-06-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Goldman | Neutral → Sell |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-18 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Reiterato | Morgan Stanley | Overweight |
| 2022-02-18 | Reiterato | Raymond James | Outperform |
| 2022-02-18 | Reiterato | Stifel | Buy |
| 2022-02-18 | Reiterato | UBS | Neutral |
| 2022-02-18 | Reiterato | Wells Fargo | Overweight |
| 2022-02-11 | Iniziato | Goldman | Neutral |
| 2022-01-07 | Ripresa | Citigroup | Buy |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-09-03 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Downgrade | UBS | Buy → Neutral |
| 2020-12-15 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-09-04 | Downgrade | Argus | Buy → Hold |
| 2020-06-24 | Iniziato | Oppenheimer | Outperform |
| 2020-03-19 | Aggiornamento | Stifel | Hold → Buy |
| 2020-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-01-02 | Aggiornamento | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-10-16 | Iniziato | Barclays | Underweight |
| 2018-05-17 | Ripresa | Piper Jaffray | Overweight |
| 2018-02-06 | Reiterato | Citigroup | Neutral |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2018-01-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
Mostra tutto
Baxter International Inc Borsa (BAX) Ultime notizie
Parenteral Formula Market Is Going to Boom | Major Giants Baxter International, Fresenius Kabi, B. Braun, Grifols - openPR.com
Baxter International Inc. (NYSE:BAX) Receives $30.11 Consensus Price Target from Analysts - MarketBeat
How Baxter International Inc. (BAX) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Baxter Launches Welch Allyn Connex 360 Vital Signs Monitor to Advance Connected Patient Monitoring - biomb.ca
Baxter to split into two companies - The Covington News
Jim Cramer on Baxter: “They Are the King of Disappointment” - MSN
Fiduciary Alliance LLC Takes $1.91 Million Position in Baxter International Inc. $BAX - MarketBeat
Will BAX's Q1 Earnings Improve Following Transformation Completion? - MSN
Baxter International’s Valuation in Focus After FDA-Cleared Vital Signs Monitor Launch - simplywall.st
Precision Trading with Baxter International Inc. (BAX) Risk Zones - news.stocktradersdaily.com
Rep. Lisa C. McClain Sells Off Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
AG2R LA Mondiale Gestion D Actifs Invests $1.02 Million in Baxter International Inc. $BAX - MarketBeat
Is Baxter International Stock Underperforming The Dow? - Barchart.com
CEO Change: Does Baxter International Inc. outperform in volatile marketsTrade Entry Report & Capital Efficiency Focused Strategies - خودرو بانک
Baxter International Inc. $BAX Position Boosted by Park National Corp OH - MarketBeat
Aug Sentiment: How does Baxter International Inc. score in quality rankingsMarket Activity Report & Weekly Watchlist of Top Performers - خودرو بانک
Baxter International Names ATS’ Andrew Hider as Next CEO - MSN
Baxter Stock Slips Despite Latest Launch to Boost Patient Monitoring - Yahoo Finance
Baxter International Inc. Stock Slides 2.8%, Underperforms Peers - 富途牛牛
Baxter Launches Welch Allyn Connex 360 Vital Signs Monitor - respiratory-therapy.com
Aug Intraday: Why is Baxter International Inc. stock going down2025 Analyst Calls & Daily Technical Stock Forecast Reports - خودرو بانک
Baxter launches next-gen Welch Allyn Connex 360 vital signs monitor - MassDevice
Baxter launches Welch Allyn Connex 360 Vital Signs Monitor - Medical Device Network
BAX Stock Declines Despite Latest Product Launch Boosting Patient Care - MSN
Stock Analysis: Does Baxter International Inc have declining or rising EPSWeekly Earnings Recap & Real-Time Price Movement Reports - خودرو بانک
Entry Recap: Should I hold or sell SCE.PRJ nowTrade Performance Summary & Step-by-Step Trade Execution Guides - خودرو بانک
YieldBoost Baxter International To 14% Using Options - Nasdaq
Baxter launches new patient monitoring device with advanced connectivity, security features - Medical Economics
Baxter International Inc. Launches Welch Allyn Connex 360 Vital Signs Monitor to Advance Connected Patient Monitoring - MarketScreener
Take Profit: Can Baxter International Inc scale operations efficientlyStock Surge & Low Risk Profit Maximizing Plans - خودرو بانک
Stock Recap: Is Baxter International Inc. a turnaround storyWeekly Profit Analysis & Verified Technical Signals - خودرو بانک
Will Baxter International Inc. stock recover after earningsJuly 2025 Retail & Weekly Hot Stock Watchlists - خودرو بانک
Baxter targets 5%-6% 2025 revenue growth amid Novum IQ pump success and operational recovery - MSN
Baxter Launches HEMOPATCH Sealing Hemostat… - digitalmore.co
Baxter Launches HEMOPATCH Sealing Hemostat in New Zealand, a Room-Temperature Collagen Pad Approved for Hemostasis and Sealing - The Manila Times
Aug Momentum: Should I add Baxter International Inc stock to my portfolio2025 Major Catalysts & Long-Term Growth Plans - khodrobank.com
Inflation Data: Is Baxter International Inc. stock trending bullish2025 Earnings Impact & Weekly Watchlist for Consistent Profits - khodrobank.com
Aug Volume: Is Baxter International Inc forming bullish engulfing patternsJuly 2025 Earnings & AI Enhanced Trading Alerts - khodrobank.com
Opportunities in the Home Infusion Therapy Market 2025-2035 Featuring Strategic Analysis of Baxter International, B. Braun Melsungen, Fresenius Kabi, Medtronic, Terumo and More - Yahoo Finance
Sciencast Management LP Takes $356,000 Position in Baxter International Inc. $BAX - MarketBeat
News impact scoring models applied to Baxter International Inc.2025 Key Lessons & Safe Entry Trade Signal Reports - newser.com
RNC Capital Management LLC Increases Holdings in Baxter International Inc. $BAX - MarketBeat
Amundi Increases Stake in Baxter International Inc. $BAX - MarketBeat
Baird Financial Group Inc. Decreases Holdings in Baxter International Inc. $BAX - MarketBeat
Baxter International Inc Azioni (BAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.14%
1.26%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):